Quest Diagnostics's market cap is currently $19.95B. The company's EPS TTM is $2.62; its P/E ratio is 21.44; and it has a dividend yield of 1.73%. Quest Diagnostics is scheduled to report earnings on July 22, 2025, and the estimated EPS forecast is $2.51. See an overview of income statement, balance sheet, and cash flow financials.
